Julio Casoy

Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA.

ArTara Subsidiary, Inc. engages in the research and development of specialty diseases therapeutics. Its programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology or gastrointestinal and metabolic disorders. The company was founded by Jesse Shefferman in 2017 and is headquartered in New York, NY.

Velocity Fund Partners (Velocity Fund Partners) is a private equity firm founded in 2016. The firm is headquartered in Pittsburgh, Pennsylvania.

InClinica, Inc. provides clinical trial services to western biotechnology, pharmaceutical and medical device companies. It also offers clinical trial management, pharmacovigilance and monitoring services. The company was founded in 2016 and is headquartered in Wayne, PA.

Vyera Pharmaceuticals LLC operates as a biopharmaceutical company that focuses on patients with unmet medical needs. Its products include Vecamyl and Daraprim. The firm engages in developing and commercializing treatments for serious diseases and conditions of therapeutic areas. The company was founded by Martin Shkreli in October 10, 2014 and is headquartered in New York, NY.

Popsi Cube SARL is a French company that operates as a clinical and digital research organization. The company is based in Montigny le Bretonneux, France. The company was founded in 2004 by Fabrice Beauchêne. Fabrice Beauchêne has been the CEO since 2004.